Dmitri Pavlov

Author PubWeight™ 22.68^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma.	J Clin Oncol	2013	5.36
2	Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.	J Clin Oncol	2005	4.77
3	Phase I/II trial of tremelimumab in patients with metastatic melanoma.	J Clin Oncol	2009	2.53
4	Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial.	Lancet Oncol	2013	2.29
5	Comorbidity as a predictor of stage of illness for patients with breast cancer.	Med Care	2005	1.55
6	Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia.	Am J Hematol	2014	1.22
7	Familial hypertrophic cardiomyopathy-related cardiac troponin C mutation L29Q affects Ca2+ binding and myofilament contractility.	Physiol Genomics	2008	1.10
8	The development and validation of a comorbidity index for prostate cancer among Black men.	J Clin Epidemiol	2003	1.04
9	Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial.	Br J Haematol	2014	0.97
10	Deciphering the binding of caveolin-1 to client protein endothelial nitric-oxide synthase (eNOS): scaffolding subdomain identification, interaction modeling, and biological significance.	J Biol Chem	2014	0.93
11	Comorbidities and the risk of late-stage prostate cancer.	ScientificWorldJournal	2006	0.85
12	Population pharmacokinetic and pharmacodynamic analysis of tremelimumab in patients with metastatic melanoma.	J Clin Pharmacol	2014	0.76